Business Context and Reporting Period
This Form 8-K is filed by BioSig Technologies, Inc. (BSGM), a Delaware corporation, with a report date of July 2, 2021. The filing addresses a specific commercial event under Item 8.01 (Other Events). Note: The request metadata references "Streamex Corp.," but the source document explicitly identifies the registrant as BioSig Technologies, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a discrete business event rather than periodic financial performance.
Material Changes
The Company received a new purchase order from the Mayo Foundation for Medical Education and Research. Key details include:
- Product: PURE EP System.
- Location: Mayo Clinic Phoenix Campus in Arizona.
- Timeline: Evaluation commenced in April 2021; the order was received as of the report date.
- Context: This follows previous acquisitions of multiple PURE EP Systems by the Mayo Foundation for its Florida and Minnesota campuses.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, management commentary on future performance, or discussion of risks and contingencies beyond the announcement of the new order.
Investor Verification Checklist
- Verify the total contract value of the new purchase order, which is not disclosed in this filing.
- Confirm the expected revenue recognition timeline for the PURE EP System deployment at the Phoenix campus.
- Review prior filings to assess the financial impact of the previously acquired systems at the Florida and Minnesota campuses.
- Monitor subsequent filings for updates on the commercial rollout of the PURE EP System.